Neurocrine Biosciences
NBIX
#1386
Rank
โ‚ฌ12.04 B
Marketcap
118,98ย โ‚ฌ
Share price
-1.18%
Change (1 day)
15.50%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ1.16 Billion

According to Neurocrine Biosciences 's latest financial reports the company has โ‚ฌ1.16 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ0.93 B1.18%
2022-12-31โ‚ฌ0.92 B46.84%
2021-12-31โ‚ฌ0.62 B-3.55%
2020-12-31โ‚ฌ0.65 B8.8%
2019-12-31โ‚ฌ0.59 B5.19%
2018-12-31โ‚ฌ0.56 B32.32%
2017-12-31โ‚ฌ0.42 B47.16%
2016-12-31โ‚ฌ0.29 B-15.74%
2015-12-31โ‚ฌ0.34 B117.63%
2014-12-31โ‚ฌ0.15 B51%
2013-12-31โ‚ฌ0.10 B-19.32%
2012-12-31โ‚ฌ0.13 B31.57%
2011-12-31โ‚ฌ99.41 M4.23%
2010-12-31โ‚ฌ95.37 M155.59%
2009-12-31โ‚ฌ37.31 M-35.17%
2008-12-31โ‚ฌ57.56 M-53.15%
2007-12-31โ‚ฌ0.12 B-11.22%
2006-12-31โ‚ฌ0.13 B-39.97%
2005-12-31โ‚ฌ0.23 B3.84%
2004-12-31โ‚ฌ0.22 B-38.33%
2003-12-31โ‚ฌ0.35 B53.76%
2002-12-31โ‚ฌ0.23 B-35.39%
2001-12-31โ‚ฌ0.36 B107.28%
2000-12-31โ‚ฌ0.17 B93.08%
1999-12-31โ‚ฌ90.53 M818.22%
1998-12-31โ‚ฌ9.85 M-25.95%
1997-12-31โ‚ฌ13.31 M39.82%
1996-12-31โ‚ฌ9.52 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ0.76 B-34.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.67 B 43.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ9.03 M-99.22%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.33 B 186.51%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.90 B 493.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.43 B 710.42%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.23 B-79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.96 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA